For example, TISAM, an N-sulfonylamino acid derivative, which selectively inhibits MMP-2, was used in a model of acute myocardial infarction, improving survival rate, preventing cardiac rupture and delaying post-infarction remodeling. This evidence concerns the gene MMP2 and myocardial infarction.